Effects of PFC tDCS on Cognitive Control, Attention Lapses and Coordinated Neural Activity in the Theta and Alpha Bands

Launched by UNIVERSITY OF CALIFORNIA, DAVIS · May 7, 2021

Keywords

ClinConnect Summary

This clinical trial is studying how a special technique called transcranial direct current stimulation (tDCS) can affect brain function, particularly focusing on cognitive control and attention. Researchers are interested in understanding how stimulating different parts of the brain can improve performance on tasks that involve thinking, memory, and understanding language. The trial will look at healthy individuals aged 18 to 50 who can speak and understand English well enough to complete tasks. Participants will use a non-invasive method to apply stimulation to their brains while performing cognitive tasks, and researchers will measure their performance and brain activity.

If you are interested in participating, you should not have a history of head injuries or be currently taking certain medications for mental health. Additionally, there are some medical conditions and physical factors that could prevent you from joining, such as pregnancy or having metal implants in your body. This study is purely for research purposes and is not designed to treat any health conditions. If you join, you'll help contribute to important knowledge about how our brains work, especially in relation to cognitive tasks.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • between ages of 18 and 50
• • ability to sufficiently speak and understand English so as to be able to understand and complete cognitive tasks
• • ability to give valid informed consent
• Exclusion Criteria:
• • no history of head trauma
• • no current or previous history of treatment with psychotropic medication
• • corrected vision 20/30 or better
• • tDCS/MRI contraindications, including: pregnancy, ferrous metal in any part of the body, serious medical conditions, claustrophobia, metallic implants, skin damage, conditions such as eczema at electrode sites, cranial pathologies